News from Economic Times Markets
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Cryptocurrency
Crypto Assets
Stocks
Investors
Stock
Shares
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Blockchain
Sec
Stablecoin
Etf
Eth
Trade
Earnings
Revenue
Solana
Index
Bse
China
Coinbase
Ipo
Token
Wall Street
Nasdaq
Interest Rates
Trade War
Inflation
Usd
Economy
Profit
Tesla
Sensex
Digital Assets
Sp 500
Federal Reserve
Gold
Nse
Nvidia
Treasury
Traders
Retail Traders
Crypto Games
Winnermining
Henty Gold Mine
Coffee Chains
Officials
Trading Range
Qfscoin
Share Structure
Club World Cup
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Economic Times Markets headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Economic Times Markets • Jun 06, 2025
Dr. Reddy’s shares rise over 1% on strategic collaboration with Alvotech for Keytruda Biosimilar
The partnership between Dr. Reddy’s and Alvotech to develop a biosimilar immunotherapy drug could enhance their positions in the rapidly expanding oncology market, potentially gene...
Read Full Article →
Economic Times Markets • Jun 05, 2025
Dr Reddy’s shares climb over 4% after Keytruda biosimilar deal with Alvotech
The partnership with Alvotech and strong quarterly profits contributed to a recent increase in the company’s stock price, though analysts continue to recommend a cautious investmen...
Read Full Article →